112 related articles for article (PubMed ID: 33089681)
1. Correction to Assessment of Oral Bioavailability and Biotransformation of Emulsified Nobiletin Using
Zhang M; Feng K; Huang G; Xin Y; Xiao J; Cao Y; Ludescher R; Ho CT; Huang Q
J Agric Food Chem; 2020 Nov; 68(44):12503. PubMed ID: 33089681
[No Abstract] [Full Text] [Related]
2. Assessment of Oral Bioavailability and Biotransformation of Emulsified Nobiletin Using
Zhang M; Feng K; Huang G; Xin Y; Xiao J; Cao Y; Ludescher R; Ho CT; Huang Q
J Agric Food Chem; 2020 Oct; 68(41):11412-11420. PubMed ID: 32935545
[TBL] [Abstract][Full Text] [Related]
3. Nobiletin exerts anti-diabetic and anti-inflammatory effects in an in vitro human model and in vivo murine model of gestational diabetes.
Nguyen-Ngo C; Salomon C; Quak S; Lai A; Willcox JC; Lappas M
Clin Sci (Lond); 2020 Mar; 134(6):571-592. PubMed ID: 32129440
[TBL] [Abstract][Full Text] [Related]
4. Bioactivation of the citrus flavonoid nobiletin by CYP1 enzymes in MCF7 breast adenocarcinoma cells.
Surichan S; Androutsopoulos VP; Sifakis S; Koutala E; Tsatsakis A; Arroo RR; Boarder MR
Food Chem Toxicol; 2012 Sep; 50(9):3320-8. PubMed ID: 22743247
[TBL] [Abstract][Full Text] [Related]
5. Viscoelastic Emulsion Improved the Bioaccessibility and Oral Bioavailability of Crystalline Compound: A Mechanistic Study Using in Vitro and in Vivo Models.
Ting Y; Jiang Y; Lan Y; Xia C; Lin Z; Rogers MA; Huang Q
Mol Pharm; 2015 Jul; 12(7):2229-36. PubMed ID: 25984595
[TBL] [Abstract][Full Text] [Related]
6. [Preparation of self-assemble nobiletin proliposomes and its pharmacokinetics in rats].
Lin W; Yao J; Zhou JP
Yao Xue Xue Bao; 2009 Feb; 44(2):192-6. PubMed ID: 19408692
[TBL] [Abstract][Full Text] [Related]
7. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.
Zhao L; Feng SS
J Pharm Sci; 2010 Aug; 99(8):3552-60. PubMed ID: 20564384
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo.
Luo G; Guan X; Zhou L
Cancer Biol Ther; 2008 Jun; 7(6):966-73. PubMed ID: 18379194
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of nobiletin on hepatocellular carcinoma in vitro and in vivo.
Ma X; Jin S; Zhang Y; Wan L; Zhao Y; Zhou L
Phytother Res; 2014 Apr; 28(4):560-7. PubMed ID: 23818450
[TBL] [Abstract][Full Text] [Related]
10. Nobiletin, a polymethoxylated flavonoid from citrus, shows anti-angiogenic activity in a zebrafish in vivo model and HUVEC in vitro model.
Lam KH; Alex D; Lam IK; Tsui SK; Yang ZF; Lee SM
J Cell Biochem; 2011 Nov; 112(11):3313-21. PubMed ID: 21748787
[TBL] [Abstract][Full Text] [Related]
11. Identification of nobiletin metabolites in mouse urine.
Li S; Wang Z; Sang S; Huang MT; Ho CT
Mol Nutr Food Res; 2006 Mar; 50(3):291-9. PubMed ID: 16521176
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine: Bioavailability, Biotransformation and Biokinetics.
Ravindran S; Tambe AJ; Suthar JK; Chahar DS; Fernandes JM; Desai V
Curr Drug Metab; 2019; 20(7):542-555. PubMed ID: 31203796
[TBL] [Abstract][Full Text] [Related]
13. Prevention of arterial thrombosis by nobiletin: in vitro and in vivo studies.
Lu WJ; Lin KC; Liu CP; Lin CY; Wu HC; Chou DS; Geraldine P; Huang SY; Hsieh CY; Sheu JR
J Nutr Biochem; 2016 Feb; 28():1-8. PubMed ID: 26878777
[TBL] [Abstract][Full Text] [Related]
14. Urinary metabolites of nobiletin orally administered to rats.
Yasuda T; Yoshimura Y; Yabuki H; Nakazawa T; Ohsawa K; Mimaki Y; Sashida Y
Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1426-8. PubMed ID: 14646323
[TBL] [Abstract][Full Text] [Related]
15. Comparison of supercritical fluid chromatography and liquid chromatography for the separation of urinary metabolites of nobiletin with chiral and non-chiral stationary phases.
Wang Z; Li S; Jonca M; Lambros T; Ferguson S; Goodnow R; Ho CT
Biomed Chromatogr; 2006 Nov; 20(11):1206-15. PubMed ID: 16799930
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on nobiletin metabolism with liver microsomes from rats, Guinea pigs and hamsters and rat cytochrome p450.
Koga N; Matsuo M; Ohta C; Haraguchi K; Matsuoka M; Kato Y; Ishii T; Yano M; Ohta H
Biol Pharm Bull; 2007 Dec; 30(12):2317-23. PubMed ID: 18057719
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition effect and its mechanism of nobiletin on proliferation of lung cancer cells].
Luo G; Zeng Y; Zhu L; Zhang YX; Zhou LM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):449-53. PubMed ID: 19627003
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of nobiletin by Aspergillus niger and the antimutagenic activity of a metabolite, 4'-hydroxy-5,6,7,8,3'-pentamethoxyflavone.
Okuno Y; Miyazawa M
J Nat Prod; 2004 Nov; 67(11):1876-8. PubMed ID: 15568779
[TBL] [Abstract][Full Text] [Related]
19. Nobiletin Enhances Induction of Antigen-Specific Immune Responses in BALB/c Mice Immunized with Ovalbumin.
Nakamoto A; Mitani M; Urayama K; Maki A; Nakamoto M; Shuto E; Nii Y; Sakai T
J Nutr Sci Vitaminol (Tokyo); 2019; 65(3):278-282. PubMed ID: 31257269
[TBL] [Abstract][Full Text] [Related]
20. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
